Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Free Report) was the recipient of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 134,000 shares, an increase of 261.2% from the December 15th total of 37,100 shares. Based on an average daily trading volume, of 34,300 […]
CAMBRIDGE, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science company committed.
Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Free Report) saw a large decrease in short interest in November. As of November 30th, there was short interest totalling 114,700 shares, a decrease of 7.0% from the November 15th total of 123,300 shares. Based on an average daily volume of 26,700 shares, the short-interest ratio is presently 4.3 […]
Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Free Report) was the target of a significant decline in short interest in the month of August. As of August 15th, there was short interest totalling 97,900 shares, a decline of 6.6% from the July 31st total of 104,800 shares. Approximately 3.2% of the company’s shares are sold short. […]